OPT - Opthea - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

141.4M

Cash

141.8M

Avg Qtr Burn

-27.97M

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

18.47%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
OPT-302 Details Wet age-related macular degeneration , Eye disease	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OPT-302 Details Diabetes, Eye disease , Diabetic macular edema	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.